EE200300512A - Aromataasi inhibiitori kasutamine abistava reproduktsiooni suurendamiseks - Google Patents

Aromataasi inhibiitori kasutamine abistava reproduktsiooni suurendamiseks

Info

Publication number
EE200300512A
EE200300512A EEP200300512A EEP200300512A EE200300512A EE 200300512 A EE200300512 A EE 200300512A EE P200300512 A EEP200300512 A EE P200300512A EE P200300512 A EEP200300512 A EE P200300512A EE 200300512 A EE200300512 A EE 200300512A
Authority
EE
Estonia
Prior art keywords
enhance
aromatase inhibitor
assisted reproduction
assisted
reproduction
Prior art date
Application number
EEP200300512A
Other languages
English (en)
Estonian (et)
Inventor
F. Casper Robert
F. M. Mitwally Mohamed
Original Assignee
Ares Trading S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.
Publication of EE200300512A publication Critical patent/EE200300512A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200300512A 2001-04-17 2002-04-17 Aromataasi inhibiitori kasutamine abistava reproduktsiooni suurendamiseks EE200300512A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28417801P 2001-04-17 2001-04-17
PCT/CA2002/000522 WO2002083240A1 (en) 2001-04-17 2002-04-17 Aromatase inhibition to enhance assisted reproduction

Publications (1)

Publication Number Publication Date
EE200300512A true EE200300512A (et) 2004-02-16

Family

ID=23089175

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300512A EE200300512A (et) 2001-04-17 2002-04-17 Aromataasi inhibiitori kasutamine abistava reproduktsiooni suurendamiseks

Country Status (33)

Country Link
US (1) US7846957B2 (xx)
EP (1) EP1381431B1 (xx)
JP (1) JP2004526764A (xx)
KR (1) KR20040012751A (xx)
CN (1) CN100377710C (xx)
AR (1) AR034310A1 (xx)
AT (1) ATE363906T1 (xx)
AU (1) AU2002249041B2 (xx)
BG (1) BG108316A (xx)
BR (1) BR0208968A (xx)
CA (1) CA2444932A1 (xx)
CY (1) CY1108021T1 (xx)
CZ (1) CZ299735B6 (xx)
DE (1) DE60220516T2 (xx)
DK (1) DK1381431T3 (xx)
EA (1) EA010354B1 (xx)
EE (1) EE200300512A (xx)
ES (1) ES2283541T3 (xx)
HK (1) HK1067987A1 (xx)
HR (1) HRP20030838A2 (xx)
HU (1) HUP0303795A2 (xx)
IL (2) IL158395A0 (xx)
MX (1) MXPA03009446A (xx)
NO (1) NO20034245L (xx)
NZ (1) NZ528501A (xx)
PL (1) PL366554A1 (xx)
PT (1) PT1381431E (xx)
SI (1) SI1381431T1 (xx)
SK (1) SK14252003A3 (xx)
UA (1) UA79591C2 (xx)
WO (1) WO2002083240A1 (xx)
YU (1) YU81303A (xx)
ZA (1) ZA200307514B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL373219A1 (en) * 2002-07-02 2005-08-22 Pharmacia & Upjohn Company Llc Infertility treatment with exemestane
US9144569B2 (en) 2010-05-20 2015-09-29 University Of Saskatchewan Methods of administering an aromatase inhibitor, prostaglandin and GnRH for regulating ovulation in cattle
WO2012127501A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for improving endometrial thickness during ovarian stimulation
KR101872561B1 (ko) 2011-09-08 2018-06-28 노파르티스 아게 아로마타제 억제제를 포함하는 제약 조성물
WO2014169395A1 (en) 2013-04-19 2014-10-23 University Of Saskatchewan Aromatase inhibitor-releasing intravaginal device
CN107648594A (zh) * 2017-11-08 2018-02-02 广州市桐晖药业有限公司 枸橼酸氯米芬胶囊及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289762A (en) * 1980-06-27 1981-09-15 Merrell Dow Pharmaceuticals Inc. 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US4845227A (en) * 1984-06-18 1989-07-04 Eli Lilly And Company Aromatase inhibitors from azoles
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
DE4330237C2 (de) * 1993-09-02 1995-11-30 Schering Ag 1-Methylsubstituierte Androsta-1,4-dien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
AU1793397A (en) 1996-03-29 1997-10-22 S.W. Patentverwertungs Ges. M.B.H. Edelsbacher U. Partner Cosmetic or cosmetic preparation for smoothing and tightening the skin in the case of subcutaneous fatty tissue problems, particularly cellulite
WO1997040846A1 (en) 1996-04-30 1997-11-06 Takeda Chemical Industries, Ltd. COMBINED USE OF GnRH AGONIST AND ANTAGONIST
DE19622457A1 (de) 1996-05-24 1997-11-27 Schering Ag 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
WO1998058657A1 (en) * 1997-06-20 1998-12-30 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
US6953774B2 (en) * 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation

Also Published As

Publication number Publication date
NO20034245D0 (no) 2003-09-23
ES2283541T3 (es) 2007-11-01
HUP0303795A2 (hu) 2004-03-29
YU81303A (sh) 2006-05-25
IL158395A0 (en) 2004-05-12
UA79591C2 (en) 2007-07-10
ATE363906T1 (de) 2007-06-15
PT1381431E (pt) 2007-07-03
US7846957B2 (en) 2010-12-07
CN100377710C (zh) 2008-04-02
AR034310A1 (es) 2004-02-18
IL158395A (en) 2009-06-15
DK1381431T3 (da) 2007-10-08
KR20040012751A (ko) 2004-02-11
HK1067987A1 (en) 2005-04-22
MXPA03009446A (es) 2004-05-24
BG108316A (bg) 2004-12-30
CZ20033108A3 (en) 2004-06-16
SI1381431T1 (sl) 2007-08-31
EA010354B1 (ru) 2008-08-29
DE60220516D1 (de) 2007-07-19
CY1108021T1 (el) 2013-09-04
NZ528501A (en) 2008-04-30
AU2002249041B2 (en) 2007-07-12
SK14252003A3 (sk) 2004-03-02
ZA200307514B (en) 2004-09-27
EP1381431B1 (en) 2007-06-06
EP1381431A1 (en) 2004-01-21
PL366554A1 (en) 2005-02-07
DE60220516T2 (de) 2007-10-11
CA2444932A1 (en) 2002-10-24
US20040204393A1 (en) 2004-10-14
CZ299735B6 (cs) 2008-11-05
BR0208968A (pt) 2004-04-27
NO20034245L (no) 2003-12-15
JP2004526764A (ja) 2004-09-02
WO2002083240A9 (en) 2004-05-06
HRP20030838A2 (en) 2005-08-31
WO2002083240A1 (en) 2002-10-24
CN1549734A (zh) 2004-11-24
EA200301129A1 (ru) 2004-04-29

Similar Documents

Publication Publication Date Title
ATE370938T1 (de) Pro-pharmakon von cox-2-inhibitoren
CY2015028I1 (el) Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
DE60321324D1 (de) Sulfonylaminoderivate als neue inhibitoren von histondeacetylase
EE200300470A (et) Aldoosreduktaasi püridasinooninhibiitorid
NO20042080L (no) Inhibitorer for post-prolin spaltningsproteaser
EE200300361A (et) PDE4 isosüümide inhibiitoritena kasutatavad eetriderivaadid
DE60211601D1 (de) Bereitstellung von positionsabhängigen Inhalten
DK1505963T3 (da) Hepatitis C-inhibitorer
DE602004008303D1 (de) Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3
DE60203995D1 (de) Triazoloverbindungen als mmp-inhibitoren
DK1252293T3 (da) Kilde til levervæv
ATE355836T1 (de) Inhibitoren der mucin-synthese
ID30187A (id) Dongkrak jenis pantagraf
NO20032441D0 (no) Kombinasjon av GABA agonister og sorbitol-dehydrogenase inhibitorer
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
ITMI20021399A1 (it) Inibitori della cicloossigenasi 2
IS7407A (is) Afleysing lausnarsambanda atorvastatínhálfkalsíums
HK1067987A1 (en) Aromatase inhibition to enhance assisted reproduction
IS6884A (is) Aðferðir við að nýta líffræðilegan fjölbreytileika
DE60226715D1 (de) Monoamin-aufnahme-inhibitor
DE60031450D1 (de) Polymorph v von torasemid
EE200200389A (et) Imidasooli uued derivaadid
DK1383578T3 (da) Enkeltdosis aromataseinhibitor til behandling af ufrugtbarhed
DE60331820D1 (de) Beseitigung von verstopfungen von rohrleitungen
ATE297382T1 (de) 3-heterocyclyl propanohydroxamsäure-derivaten als pcp inhibitoren

Legal Events

Date Code Title Description
HE1A Change of address